Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

被引:195
作者
Miyagi, Eri [1 ]
Andrew, Amy J. [1 ]
Kao, Sandra [1 ]
Strebel, Klaus [1 ]
机构
[1] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
CD317; host restriction; tetherin; virus assembly; INTEGRAL MEMBRANE-PROTEIN; TYPE-1; VPU; MOLECULAR-CLONING; PARTICLE RELEASE; INHIBITS HIV-1; IDENTIFICATION; MACROPHAGES; EXPRESSION; GENE; GAG;
D O I
10.1073/pnas.0813223106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HIV-1 Vpu enhances the release of virions from infected cells. Recent work identified Bst-2/CD317/tetherin as a host factor whose inhibitory activity on viral release is counteracted by Vpu. A current working model proposes that Bst-2 inhibits virus release by tethering viral particles to the cell surface. Here, we analyzed endogenous Bst-2 with respect to its effect on virus release from HeLa cells, T cells, and macrophages. We noted significant cell type-dependent variation in Bst-2 expression. Vpu caused a reduction in Bst-2 expression in transfected HeLa cells and long-term infected macrophages. However, Vpu expression did not result in cell surface down-modulation of Bst-2 or a reduction in intracellular Bst-2 expression in CEMx174 or H9 cells, yet virus replication in these cells was Vpu-responsive. Surprisingly, Bst-2 was undetectable in cell-free virions that were recovered from the surface of HeLa cells by physical shearing, suggesting that a tethering model may not explain all of the functional properties of Bst-2. Taken together we conclude that enhancement of virus release by Vpu does not, at least in CEMx174 and H9 cells, require cell surface down-modulation or intracellular depletion of Bst-2, nor does it entail exclusion of Bst-2 from viral particles.
引用
收藏
页码:2868 / 2873
页数:6
相关论文
共 42 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor κB-dependent expression of antiapoptotic factors [J].
Akari, H ;
Bour, S ;
Kao, S ;
Adachi, A ;
Strebel, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (09) :1299-1311
[3]   Quantitative membrane proteomics reveals new cellular targets of viral immune modulators [J].
Bartee, Eric ;
McCormack, Ashley ;
Fruh, Klaus .
PLOS PATHOGENS, 2006, 2 (10) :975-988
[4]   Cell surface CD4 inhibits HTV-1 particle release by interfering with Vpu activity [J].
Bour, S ;
Perrin, C ;
Strebel, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33800-33806
[5]   Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family [J].
Callahan, MA ;
Handley, MA ;
Lee, YH ;
Talbot, KJ ;
Harper, JW ;
Panganiban, AT .
JOURNAL OF VIROLOGY, 1998, 72 (06) :5189-5197
[6]   IDENTIFICATION OF A PROTEIN ENCODED BY THE VPU GENE OF HIV-1 [J].
COHEN, EA ;
TERWILLIGER, EF ;
SODROSKI, JG ;
HASELTINE, WA .
NATURE, 1988, 334 (6182) :532-534
[7]   The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels [J].
Ewart, GD ;
Sutherland, T ;
Gage, PW ;
Cox, GB .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7108-7115
[8]   Differential Sensitivity of "Old" versus "New" APOBEC3G to Human Immunodeficiency Virus Type 1 Vif [J].
Goila-Gaur, Ritu ;
Khan, Mohammad A. ;
Miyagi, Eri ;
Strebel, Klaus .
JOURNAL OF VIROLOGY, 2009, 83 (02) :1156-1160
[9]  
GOTO T, 1994, BLOOD, V84, P1922
[10]  
GRUBER MF, 1995, J IMMUNOL, V154, P5528